<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03916692</url>
  </required_header>
  <id_info>
    <org_study_id>FP00016578</org_study_id>
    <nct_id>NCT03916692</nct_id>
  </id_info>
  <brief_title>GRAPE • Glycemic Response of Amylopectin Containing Drinks</brief_title>
  <acronym>GRAPE</acronym>
  <official_title>Glycemic Response of Amylopectin Containing Drinks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Standard Process Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To quantify the glycemic index of the SP energy-smart-based nutrition supplement and the SP
      Glucose-support formula as compared to a glucose drink. We hypothesized that both the
      energy-smart-based nutritional supplement and the SP Glucose-support formula will have low
      glycemic index.

      The aim of the study is to quantify the glycemic index of the SP energy-smart-based nutrition
      supplement and the SP Glucose-support formula as compared to a glucose drink. We hypothesized
      that both the energy-smart-based nutritional supplement and the SP Glucose-support formula
      will have low glycemic index.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects: 9 non-diabetic (HbA1c &lt; 6.5) males aged 30-55 years with body mass indices ranging
      from 27.5 to 35 kg∙m-2. Individuals with impaired glucose tolerance will be included as long
      as they are not diagnosed with diabetes and their HbA1c is less than 6.5.

      Preliminary Testing: Medical history, weight, height, body composition via dual x-ray
      absorptiometry (DXA) and glycosylated hemoglobin (HbA1c) measurement.

      Protocol: After a 10-hour overnight fast, subjects will complete 3 experimental visits in
      which they will ingest one of three beverages in a randomized order. During experimental
      visits subjects will either be given the following 3 experimental drinks:

        -  Full SP-glucose balance formula (200 kcal)

        -  Energy smart carbohydrate blend (50 g, 200 kcal)

        -  Liquid dextrose solution in the form of TRUTOL ® Glucose Tolerance Test Beverage (50 g,
           200 kcal)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2019</start_date>
  <completion_date type="Anticipated">December 20, 2020</completion_date>
  <primary_completion_date type="Actual">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized Cross-over trial</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area Under the Curve of Glucose</measure>
    <time_frame>120 minutes</time_frame>
    <description>Positive integer of the area under the Curve of glucose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area Under the Curve for Insulin</measure>
    <time_frame>120 minutes</time_frame>
    <description>Positive integer of the area under the Curve of insulin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>30, 60 and 120 minutes of the glucose challenge</time_frame>
    <description>Blood glucose levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood insulin</measure>
    <time_frame>30, 60 and 120 minutes of the glucose challenge</time_frame>
    <description>Blood insulin levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>c-peptide</measure>
    <time_frame>30, 60, and 120 minutes of the glucose challenge</time_frame>
    <description>Blood levels of c-peptide</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucagon</measure>
    <time_frame>30, 60, and 120 minutes of of the glucose challenge</time_frame>
    <description>Blood levels of glucagon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leptin</measure>
    <time_frame>30, 60, and 120 minutes of the glucose challenge</time_frame>
    <description>Blood levels of leptin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adiponectin</measure>
    <time_frame>30, 60, and 120 minutes of the glucose challenge</time_frame>
    <description>Blood levels of adiponectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucagon-like-peptide-1</measure>
    <time_frame>30, 60, and 120 minutes of the glucose challenge</time_frame>
    <description>Blood levels of glucagon-like-peptide-1</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">9</enrollment>
  <condition>Glycemic Index</condition>
  <arm_group>
    <arm_group_label>Standard Process - glucose balance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard Process - glucose balance formula (200 kcal)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Energy smart Carbohydrate blend</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Energy smart carbohydrate blend (50 grams, 200 kcal)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liquid Dextrose Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liquid dextrose solution in the form of TRUTOL ® Glucose Tolerance Test Beverage (50 grams, 200 kcal)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Carbohydrate drink</intervention_name>
    <description>Meal replacement drink containing 200 kcal</description>
    <arm_group_label>Standard Process - glucose balance</arm_group_label>
    <other_name>SP-glucose balance formula</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Energy smart Carbohydrate blend</intervention_name>
    <description>Carbohydrate blend drink designed for low glycemic responses containing 200 kcal</description>
    <arm_group_label>Energy smart Carbohydrate blend</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Liquid Dextrose</intervention_name>
    <description>Liquid Dextrose drink of 200 kcal</description>
    <arm_group_label>Liquid Dextrose Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 27.5 to 35 kg∙m-2

        Exclusion Criteria:

          -  Diagnosed diabetes

          -  HbA1c &gt; 6.5

          -  competitive athletes

          -  body weigh change &gt; 3kg during last month
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>self-reported</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stavros Kavouras, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stavros Kavouras, PhD</last_name>
    <phone>6028272265</phone>
    <email>stavros.kavouras@asu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adam Seal, MS</last_name>
    <email>ada.seal@asu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona Biomedical Collaborative</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stavros Kavouras, PhD</last_name>
      <phone>602-827-2265</phone>
      <email>stavros.kavouras@asu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Adam Seal, MS</last_name>
      <phone>(479) 531-6059</phone>
      <email>adam.seal@asu.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>April 4, 2020</last_update_submitted>
  <last_update_submitted_qc>April 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

